Edgewise Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Edgewise Therapeutics, Inc.
CIK #0001710072
EDGAR Form CIK 2011 - 2025
10-K [0001710072]
10-Q [0001710072]
3 [0001710072]
4 [0001710072]
8-K [0001710072]
D [0001710072]
SC 13D [0001710072]
SC 13G [0001710072]
Form 13D/13G Filer Form 13D/13G Subject Filed
Perceptive Advisors LLC Edgewise Therapeutics Inc [2025-02-21]
Janus Henderson Group PLC Edgewise Therapeutics Inc [2025-02-14]
Paradigm Biocapital Advisors LP Edgewise Therapeutics Inc [2025-02-03]
Baker Bros Advisors LP Edgewise Therapeutics Inc [2024-11-14]
BlackRock Inc Edgewise Therapeutics Inc [2024-11-08]
BlackRock Inc Edgewise Therapeutics Inc [2024-10-22]
BlackRock Inc Edgewise Therapeutics Inc [2024-02-02]
RA Capital Management LP Edgewise Therapeutics Inc [2024-01-29]
EcoR1 Capital LLC Edgewise Therapeutics Inc [2022-09-26]
Deep Track Capital LP Edgewise Therapeutics Inc [2022-09-23]
View All
Form 3/4/5 Subject 2011 - 2025
Edgewise Therapeutics, Inc.
Derakhshan Behrad
Carruthers R Michael
Koch Kevin
Donovan Joanne M.
Blaustein Robert
Russell Alan J
Moore John R
Fox Jonathan C
Brege Laura
Thompson Peter A.
Root Jonathan D
Morris Arlene
Edris Badreddin
OrbiMed Capital GP VI LLC
OrbiMed Advisors LLC
OrbiMed Genesis GP LLC
Semigran Marc
Novo Holdings A/S
Wellington Biomedical Innovation Master Investors (Cayman) I
Flynn James E
Deerfield Private Design Fund IV, L.P.
Deerfield Management Company LP
Deerfield Mgmt IV, L.P.
Harrison Kenneth Ph.D.
Terms | Privacy | Guide
tony@aum13f.com